IGC Pharma, Inc. IGC
Set alert
0.20 USD 0.00 +2.02%
As of Nov 3, 10:07 AM ET
0.1927 Day range 0.1969
0.08 52-week range 0.40
- YTD
- -29.71%
- 1 year
- -50.80%
- Open
- 0.1927
- Prev close
- 0.1929
- Mkt cap
- 20.36M
- Vol
- 18.79K
- Avg vol
- 752.75K
- EPS
- -0.07
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1927
- High
- 0.1969
- Forward P/E
- -3.74
- Beta
- 1.29
- Short ratio
- 2.29
- Inst. own
- 22.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 0.3768
- 200-d avg
- 0.421
- 1y target
- 3.75
3M chart
Signals (16)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 29, 2026 | 5 days ago |
| RSI: Oversold | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 2 months ago |
| RSI: Overbought | Aug 27, 2026 | 2 months ago |
| RSI: Overbought | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
Financial health
Altman Z-Score
-18.46 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E -3.6×
FY 2017 5y median -3.1× FY 2026
P/S 21.1×
FY 2017 5y median 20.8× FY 2026
P/B 4.1×
FY 2017 5y median 3.4× FY 2026
P/FCF -4.1×
FY 2017 5y median -4.1× FY 2026
EV/EBITDA -4.0×
FY 2017 5y median -2.6× FY 2026
EV/Sales 21.7×
FY 2017 5y median 20.2× FY 2026
FCF Yield -24.4%
FY 2017 5y median -24.2% FY 2026
Profitability
Gross Margin 29.7%
FY 2017 5y median 48.7% FY 2026
Operating Margin -860.3%
FY 2017 5y median -860.3% FY 2026
Net Margin -552.1%
FY 2017 5y median -966.5% FY 2026
ROE -107.0%
FY 2017 5y median -107.0% FY 2026
ROIC -144.8%
FY 2017 5y median -113.0% FY 2026
ROA -71.3%
FY 2017 5y median -71.3% FY 2026
Growth (YoY)
Revenue -6.7%
FY 2017 FY 2026
Operating Income -37.0%
FY 2017 FY 2026
EPS (diluted) 22.3%
FY 2017 FY 2026
Free Cash Flow -15.7%
FY 2017 FY 2026
Financial Health
Current Ratio 0.4×
FY 2017 5y median 1.6× FY 2026
Quick Ratio 0.2×
FY 2017 5y median 0.9× FY 2026
Debt / Equity 0.2×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -0.1×
FY 2017 5y median 0.1× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31
